Pharma sales were down 2% on this basis with ... we will restore earnings and returns to where they should be in Croda. So starting with customer intimacy with local and regional customers.
This time last year, Croda Pharma and Botanical Solution Inc (BSI) announced that they’d entered into a strategic collaboration agreement to support the sustainable sourcing of pharmaceutical ...
Croda Earnings: Volume Recovery Drives Sequential Operating Margin Improvement, but Progress Is Slow
Croda delivered 2024 adjusted profit before tax of GBP 260 million, at the low end of its target range and broadly aligned with our forecast. Management expects some recovery in 2025 but remains ...
Croda International reported a slight decline in sales for 2024, with revenue falling one per cent at constant currency to £1.63bn. Excluding Covid-19-related lipid sales from 2023, underlying ...
Croda (CRDA) expects to see sales and profit growth return ... stabilised market share at consumer care, solid pharma growth, and a timetable for capacity benefits after higher capex. There were some ...
The projected fair value for Croda International is UK£24.72 based on 2 Stage Free Cash Flow to Equity Current share price of UK£32.20 suggests Croda International is potentially 30% overvalued ...
Veterinary Excipients Market Growth 2025 BURLINGAME, CA, UNITED STATES, February 17, 2025 /EINPresswire / -- The Global Veterina ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results